PALONOSETRON TEVA Israel - English - Ministry of Health

palonosetron teva

teva israel ltd - palonosetron as hydrochloride - solution for injection - palonosetron as hydrochloride 0.05 mg/ml - palonosetron - palonosetron teva is indicated in adults and in paediatric patients 1 month of age and older for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy, and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

PALONOSETRON 250 Microgram Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

palonosetron 250 microgram solution for injection

fresenius kabi limited - palonosetron hydrochloride - solution for injection - 250 microgram - serotonin (5ht3) antagonists

Palonosetron 250micrograms5ml solution for injection vials United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

palonosetron 250micrograms5ml solution for injection vials

accord healthcare ltd - palonosetron hydrochloride - solution for injection - 50microgram/1ml

Palonosetron 250 micrograms solution for injection in pre-filled syringe Ireland - English - HPRA (Health Products Regulatory Authority)

palonosetron 250 micrograms solution for injection in pre-filled syringe

fresenius kabi deutschland gmbh - palonosetron hydrochloride - solution for injection in pre-filled syringe - 250 microgram(s) - serotonin (5ht3) antagonists; palonosetron

Palonosetron Fresenius Kabi 250 µg inj. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

palonosetron fresenius kabi 250 µg inj. sol. i.v. vial

fresenius kabi sa-nv - palonosetron hydrochloride 0,056 mg/ml - eq. palonosetron 0,05 mg/ml - solution for injection - 250 µg - palonosetron hydrochloride 0.056 mg/ml - palonosetron

Palonosetron Fresenius Kabi 250 µg inj. sol. i.v. pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

palonosetron fresenius kabi 250 µg inj. sol. i.v. pre-filled syr.

fresenius kabi sa-nv - palonosetron hydrochloride 0,056 mg/ml - eq. palonosetron 0,05 mg/ml - solution for injection in pre-filled syringe - 250 µg - palonosetron hydrochloride 0.056 mg/ml - palonosetron

Palonosetron Sandoz 250 µg inj. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

palonosetron sandoz 250 µg inj. sol. i.v. vial

sandoz sa-nv - palonosetron hydrochloride 0,056 mg/ml - eq. palonosetron 0,05 mg/ml - solution for injection - 250 µg - palonosetron hydrochloride 0.281 mg - palonosetron

Palonosetron Juta 250 µg inj. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

palonosetron juta 250 µg inj. sol. i.v. vial

juta pharma gmbh - palonosetron hydrochloride 0,056 mg/ml - eq. palonosetron 0,05 mg/ml - solution for injection - 250 µg - palonosetron hydrochloride 0.056 mg/ml - palonosetron

PALONOSETRON BAXTER palonosetron (as hydrochloride) 250 microgram/5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

palonosetron baxter palonosetron (as hydrochloride) 250 microgram/5 ml solution for injection vial

baxter healthcare pty ltd - palonosetron hydrochloride, quantity: 280 microgram (equivalent: palonosetron, qty 250 microgram) - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium citrate dihydrate; sodium hydroxide; mannitol; disodium edetate; citric acid monohydrate - palonosetron baxter is indicated for:,? prevention of nausea and vomiting induced by cytotoxic chemotherapy,? prevention of postoperative nausea and vomiting (ponv) for up to 24 hours following surgery.

PALOCIP palonosetron hydrochloride 250 microgram/5 mL solution for injection Australia - English - Department of Health (Therapeutic Goods Administration)

palocip palonosetron hydrochloride 250 microgram/5 ml solution for injection

cipla australia pty ltd - palonosetron hydrochloride, quantity: 280.8 microgram (equivalent: palonosetron, qty 250 microgram) - injection, solution - excipient ingredients: citric acid monohydrate; mannitol; disodium edetate; sodium citrate dihydrate; hydrochloric acid; water for injections; sodium hydroxide - indicated for prevention of nausea and vomiting induced by cytotoxic chemotherapy.